Literature DB >> 15578430

Expression of the ets-1 proto-oncogene in human breast carcinoma: differential expression with histological grading and growth pattern.

S Katayama1, T Nakayama, M Ito, S Naito, I Sekine.   

Abstract

The proto-oncogene, ets-1, is a transcription factor known to control the expression of a number of genes and has been postulated to play a role in cell growth, differentiation and tumour invasion. We examined 137 cases of breast carcinoma by immunohistochemistry and compared the degree of Ets-1 expression among the different histological types of invasive carcinomas. Ets-1 was not expressed in the normal breast epithelium nor in noninvasive carcinomas. Among the 137 breast carcinoma cases, 104 (83.2%) showed positive staining for the Ets-1 protein. Histologically, invasive ductal carcinomas expressed immunopositivity with intense staining for Ets-1 in the tumour cells. Ets-1 expression correlated with Bloom-Richardson grading in invasive ductal carcinoma (p<0.01). However, there was no correlation between Ets-1 expression and lymph node metastasis, "t" classification or TNM staging. In situ hybridization confirmed the presence of Ets-1 mRNA in breast carcinomas. The expression of Ets-1 mRNA was detected in two of three different kinds of cultured human breast carcinoma cell lines and one of three human breast carcinoma tissues by the reverse transcription polymerase chain reaction method. These findings suggest that ets-1 is overexpressed in ductal cells of the breast that have undergone malignant conversion and that ets-1 is one of the factors associated with tumour growth and histological differentiation of breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15578430     DOI: 10.14670/HH-20.119

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  12 in total

1.  Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation.

Authors:  Valentina Lulli; Paolo Romania; Roberta Riccioni; Alessandra Boe; Francesco Lo-Coco; Ugo Testa; Giovanna Marziali
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

2.  PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1.

Authors:  Tamotsu Nishida; Motoko Terashima; Kiyoko Fukami; Yoshiji Yamada
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

3.  MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer.

Authors:  Wentao Li; Wenqiao Zang; Pei Liu; Yuanyuan Wang; Yuwen Du; Xiaonan Chen; Meng Deng; Wencong Sun; Lei Wang; Guoqiang Zhao; Baoping Zhai
Journal:  Tumour Biol       Date:  2014-08-02

4.  Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.

Authors:  Kimberley D Gutierrez; Valerie A Morris; David Wu; Serge Barcy; Michael Lagunoff
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

5.  Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma.

Authors:  Chia-Lung Tsai; Shih-Ming Jung; Lang-Ming Chi; Chi-Neu Tsai; Chiao-Yun Lin; Angel Chao; Yun-Shien Lee
Journal:  Aging (Albany NY)       Date:  2021-05-23       Impact factor: 5.682

6.  Bioinformatic screening of human ESTs for differentially expressed genes in normal and tumor tissues.

Authors:  Abdel Aouacheria; Vincent Navratil; Audrey Barthelaix; Dominique Mouchiroud; Christian Gautier
Journal:  BMC Genomics       Date:  2006-04-26       Impact factor: 3.969

7.  The level of Ets-1 protein is regulated by poly(ADP-ribose) polymerase-1 (PARP-1) in cancer cells to prevent DNA damage.

Authors:  Arnaud J Legrand; Souhaila Choul-Li; Corentin Spriet; Thierry Idziorek; Dorothée Vicogne; Hervé Drobecq; Françoise Dantzer; Vincent Villeret; Marc Aumercier
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

8.  Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer.

Authors:  Meghan L Verschoor; Gurmit Singh
Journal:  Mol Cancer       Date:  2013-11-15       Impact factor: 27.401

9.  Requirement of PEA3 for transcriptional activation of FAK gene in tumor metastasis.

Authors:  Shufeng Li; Xiaofeng Huang; Dapeng Zhang; Qilai Huang; Guoshun Pei; Lixiang Wang; Wenhui Jiang; Qingang Hu; Renxiang Tan; Zi-Chun Hua
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

10.  Ets-1 global gene expression profile reveals associations with metabolism and oxidative stress in ovarian and breast cancers.

Authors:  Meghan L Verschoor; Chris P Verschoor; Gurmit Singh
Journal:  Cancer Metab       Date:  2013-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.